REQUEST A DEMO
Total
USD $0.00
Search more companies

Antengene Corporation Limited (德琪医药有限公司) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Antengene Corporation Limited Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Antengene Corporation Limited (德琪医药有限公司) is a company in Hong Kong SAR, China, with a head office in Shanghai. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on August 28, 2018. There are currently 169 (2024) people employed by Antengene Corporation Limited (德琪医药有限公司). The latest financial highlights indicate a net sales revenue drop of 13.75% in Q2C2025. During that time, Antengene Corporation Limited (德琪医药有限公司)’s total assets decreased by 13.32%. The net profit margin of Antengene Corporation Limited (德琪医药有限公司) increased by 131.2% in 2025.

Headquarters
Suites 1206-1209, Block B, Zhongshan Soho Plaza, 1065 West Zhongshan Road, Changning District
Shanghai; Shanghai;

Contact Details: Purchase the Antengene Corporation Limited (德琪医药有限公司) report to view the information.

Website: http://www.antengene.com

Basic Information
Total Employees:
Purchase the Antengene Corporation Limited (德琪医药有限公司) report to view the information.
Outstanding Shares:
Purchase the Antengene Corporation Limited (德琪医药有限公司) report to view the information.
Registered Capital:
Purchase the Antengene Corporation Limited (德琪医药有限公司) report to view the information.
Financial Auditors:
Purchase the Antengene Corporation Limited (德琪医药有限公司) report to view the information.
Incorporation Date:
August 28, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
25.89%
Purchase this report to view the information.
9.23%
Purchase this report to view the information.
9.23%
Purchase this report to view the information.
6.82%
Purchase this report to view the information.
5.73%
Subsidiaries
Aim Corporation Limited
100%
Antengene (Bvi) Limited (United Kingdom)
100%
Antengene (Singapore) Pte. Ltd. (Singapore)
100%
Company Performance
Financial values in the chart are available after Antengene Corporation Limited (德琪医药有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.75%
Total Operating Revenue
9.12%
Operating Profit
49.62%
EBITDA
51.09%
Net Profit/Loss for the Period
54.93%
Total Assets
-13.32%
Total Equity
-22.81%
Operating Profit Margin
132.13%
Net Profit Margin
131.2%
Return on Equity (ROE)
6.84%
Debt / Equity
11292%
Quick Ratio
-1439.05%
Cash Ratio
-1.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?